Support legislation to tighten the Hatch-Waxman Act by limiting automatic 30-month stays and closing loopholes that delay generic drug competition.

To stop this abuse, I have written legislation with Sen. John Edwards (D-NC) to tighten the Hatch-Waxman Act that will lead to more affordable generic drugs, thus saving consumers billions of dollars.

Collins commits to legislation that would make generic drugs more affordable by curbing patent-lag tactics and speeding competition.

IMPROVING ACCESS TO AFFORDABLE PRESCRIPT... | U.S. Senator Susan Collins
primary · press_release · model gpt-5.4-mini

Collins said the Greater Access to Affordable Pharmaceuticals Act would "limit brand name manufacturers to a single 30-month stay" and prevent stacking multiple automatic stays to keep generics off the market.

Official campaign-era statement shows Collins explicitly endorsed legislation to tighten Hatch-Waxman by limiting 30-month stays and closing loopholes that delay generics.

partial same_term A for effort

Senator Susan Collins Introduces Bill to Lower Cost Prescription Drugs for Everyone
secondary · model gpt-5.4-mini · confidence 98%

On the conference report for H.R. 1, Susan Collins voted Yea; the measure title states it was an act to strengthen and improve Medicare, and the conference report included access-to-affordable-pharmaceuticals provisions.

Confirms Collins supported the enacted Medicare bill that carried the generic-drug patent reforms she had championed earlier.

partial same_term A for effort

U.S. Senate Roll Call Votes 108th Congress - 1st Session, Vote 459
secondary · model gpt-5.4-mini · confidence 86%

Title XI is labeled "Access to Affordable Pharmaceuticals." Section 1101 is "Thirty-Month Stay-of-Effectiveness Period" and amends Hatch-Waxman timing rules; Section 1102 adds forfeiture of the 180-day exclusivity period.

The federal law enacted during Collins's term implemented the core Hatch-Waxman tightening she sought, including the 30-month stay rules and anti-delay provisions.

delivered same_term

Public Law 108-173, Medicare Prescription Drug, Improvement, and Modernization Act of 2003
secondary · model gpt-5.4-mini · confidence 97%